Inactive Instrument

Company Therapix Biosciences Ltd TEL AVIV STOCK EXCHANGE

Equities

IL0010951403

Pharmaceuticals

End-of-day quote TEL AVIV STOCK EXCHANGE
- ILa - Intraday chart for Therapix Biosciences Ltd

Business Summary

Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

Sales per Business

USD in Million2022Weight2023Weight Delta
Drug Development
100.0 %
- - 3 100.0 % -

Sales per region

USD in Million2022Weight2023Weight Delta
Israel
100.0 %
1 100.0 % 3 100.0 % +113.73%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,586,686 2,586,515 ( 99.99 %) 0 99.99 %

Shareholders

NameEquities%Valuation
Yorkville Advisors Global LP
2.256 %
55,293 2.256 % 97 869 ILa
UBS Securities LLC
0.3007 %
7,370 0.3007 % 13 045 ILa
IBI Mutual Funds Management (1978) Ltd.
0.0553 %
1,356 0.0553 % 2 400 ILa
341 0.0139 % 604 ILa
Itschak Shrem
0.006038 %
148 0.006038 % 262 ILa
Excellence Nessuah Mutual Funds Management Ltd.
0.006038 %
148 0.006038 % 262 ILa
RhumbLine Advisers LP
0.001387 %
34 0.001387 % 60 ILa
7 0.000286 % 12 ILa
Lior Vider
0.000000 %
0 0.000000 % - ILa
Amnon Ben Shay
0.000000 %
0 0.000000 % - ILa

Holdings

NameEquities%Valuation
7,692 0.24% 8,846 $

Company contact information

SciSparc Ltd.

20 Raul Wallenberg Street` Tower A

6971916, Tel Aviv

+

http://www.scisparc.com
address Therapix Biosciences Ltd
  1. Stock Market
  2. Equities
  3. SPRC Stock
  4. Stock
  5. Company Therapix Biosciences Ltd